Home LiteratureArticle Details
PMID: 9405367 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation.

The EMBO journal ·Vol. 16 ·No. 24 ·1997-12-15 ·Pages 7382-92

Klefstrom J, Arighi E, Littlewood T, Jäättelä M, Saksela E, Evan GI, Alitalo K

Abstract

Normal fibroblasts are resistant to the cytotoxic action of tumor necrosis factor (TNF), but are rendered TNF-sensitive upon deregulation of c-Myc. To assess if oncoproteins induce the cytotoxic TNF activity by modulating TNF signaling, we investigated the TNF-elicited signaling responses in fibroblasts containing a conditionally active c-Myc protein. In association with cell death, c-Myc impaired TNF-induced activation of phospholipase A2, JNK protein kinase and cell survival-signaling-associated NF-kappaB transcription factor complex. The TNF-induced death of mouse primary fibroblasts expressing deregulated c-Myc was inhibited by transient overexpression of the p65 subunit of NF-kappaB, which increased NF-kappaB activity in the cells. Unlike other TNF-induced signals, TNF-induced accumulation of the wild-type p53 mRNA and protein was not inhibited by c-Myc. TNF, with c-Myc, induced apoptosis in mouse primary fibroblasts but only weakly in p53-deficient primary fibroblasts. The C-terminal domain of p53, which is a transacting dominant inhibitor of wild-type p53, failed to inhibit apoptosis by c-Myc and TNF, suggesting that the cell death was not dependent on the transcription-activating function of p53. Taken together, the present findings show that the cytotoxic activity of TNF towards oncoprotein-expressing cells involves p53 and an impaired signaling for survival in such cells.

MeSH Terms
3T3 Cells Animals Apoptosis Calcium-Calmodulin-Dependent Protein Kinases/metabolism Cell Line Cell Survival/drug effects Embryo, Mammalian Enzyme Activation Fibroblasts/cytology,drug effects,physiology Insulin-Like Growth Factor I/pharmacology JNK Mitogen-Activated Protein Kinases Membrane Proteins/metabolism Mice Mitogen-Activated Protein Kinases NF-kappa B/metabolism Phospholipases A/metabolism Phospholipases A2 Proto-Oncogene Proteins c-myc/biosynthesis,physiology RNA, Messenger/biosynthesis Rats Recombinant Fusion Proteins/metabolism Signal Transduction Transcription, Genetic Tumor Necrosis Factor-alpha/pharmacology Tumor Suppressor Protein p53/biosynthesis,deficiency,physiology bcl-2 Homologous Antagonist-Killer Protein
Chemicals
Bak1 protein, mouse Bak1 protein, rat Membrane Proteins NF-kappa B Proto-Oncogene Proteins c-myc RNA, Messenger Recombinant Fusion Proteins Tumor Necrosis Factor-alpha Tumor Suppressor Protein p53 bcl-2 Homologous Antagonist-Killer Protein Insulin-Like Growth Factor I Calcium-Calmodulin-Dependent Protein Kinases JNK Mitogen-Activated Protein Kinases Mitogen-Activated Protein Kinases Phospholipases A Phospholipases A2
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Klefstrom J
Molecular/Cancer Biology Laboratory, Haartman Institute, PO Box 21, 00014 University of Helsinki, Finland.
Arighi E
Littlewood T
Jäättelä M
Saksela E
Evan G I
Alitalo K
References (53)
53 references, click to expand
  1. The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells.
    J Virol. 1991 Mar;65(3):1236-44 PMID: 1825340
  2. Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells.
    Mol Cell Biol. 1994 Sep;14(9):5661-70 PMID: 8065303
  3. Induction of apoptosis in fibroblasts by c-myc protein.
    Cell. 1992 Apr 3;69(1):119-28 PMID: 1555236
  4. Oncogenic forms of p53 inhibit p53-regulated gene expression.
    Science. 1992 May 8;256(5058):827-30 PMID: 1589764
  5. Dominant negative MYC blocks transformation by ABL oncogenes.
    Cell. 1992 Sep 18;70(6):901-10 PMID: 1525828
  6. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.
    Mol Cell Biol. 1992 Dec;12(12):5581-92 PMID: 1448088
  7. cPLA2 is phosphorylated and activated by MAP kinase.
    Cell. 1993 Jan 29;72(2):269-78 PMID: 8381049
  8. Inducers of the heat shock response stimulate phospholipase C and phospholipase A2 activity in mammalian cells.
    J Cell Physiol. 1993 May;155(2):248-56 PMID: 8482717
  9. Negative regulation of immunoglobulin kappa light-chain gene transcription by a short sequence homologous to the murine B1 repetitive element.
    Mol Cell Biol. 1993 Jun;13(6):3698-705 PMID: 8497276
  10. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms.
    Genes Dev. 1993 Jul;7(7A):1266-76 PMID: 8319912
  11. Mediation of c-Myc-induced apoptosis by p53.
    Science. 1994 Sep 30;265(5181):2091-3 PMID: 8091232
  12. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha.
    EMBO J. 1994 Nov 15;13(22):5442-50 PMID: 7957110
  13. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.
    Genes Dev. 1994 Dec 1;8(23):2817-30 PMID: 7995520
  14. Transcriptional repression by the C-terminal domain of p53.
    Oncogene. 1995 Feb 16;10(4):671-80 PMID: 7862444
  15. Induction of apoptosis by the Bcl-2 homologue Bak.
    Nature. 1995 Apr 20;374(6524):733-6 PMID: 7715730
  16. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.
    Nucleic Acids Res. 1995 May 25;23(10):1686-90 PMID: 7784172
  17. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
    Genes Dev. 1995 Nov 15;9(22):2723-35 PMID: 7590248
  18. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms.
    Oncogene. 1995 Dec 7;11(11):2411-8 PMID: 8570193
  19. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.
    Nature. 1996 Jan 4;379(6560):88-91 PMID: 8538748
  20. Oxidative stress mediates synthesis of cytosolic phospholipase A2 after UVB injury.
    Biochim Biophys Acta. 1996 Jan 5;1299(1):23-33 PMID: 8555249
  21. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.
    Cell. 1996 Jan 26;84(2):299-308 PMID: 8565075
  22. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation.
    Nucleic Acids Res. 1996 Jan 1;24(1):141-6 PMID: 8594564
  23. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.
    Nature. 1996 Mar 7;380(6569):75-9 PMID: 8598911
  24. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death.
    Cell. 1996 Jun 14;85(6):803-15 PMID: 8681376
  25. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.
    Cell. 1996 Jun 14;85(6):817-27 PMID: 8681377
  26. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.
    Science. 1996 Nov 1;274(5288):782-4 PMID: 8864118
  27. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.
    Science. 1996 Nov 1;274(5288):784-7 PMID: 8864119
  28. Suppression of TNF-alpha-induced apoptosis by NF-kappaB.
    Science. 1996 Nov 1;274(5288):787-9 PMID: 8864120
  29. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death.
    Cell. 1996 Nov 1;87(3):565-76 PMID: 8898208
  30. Three distinct signalling responses by murine fibroblasts to genotoxic stress.
    Nature. 1996 Nov 21;384(6606):273-6 PMID: 8918879
  31. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway.
    Cell. 1997 Jan 24;88(2):213-22 PMID: 9008162
  32. p53, the cellular gatekeeper for growth and division.
    Cell. 1997 Feb 7;88(3):323-31 PMID: 9039259
  33. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.
    Nature. 1997 Aug 7;388(6642):548-54 PMID: 9252186
  34. An endotoxin-induced serum factor that causes necrosis of tumors.
    Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666-70 PMID: 1103152
  35. Preparations of lymphotoxin induce resistance to their own cytotoxic effect.
    J Immunol. 1984 May;132(5):2464-9 PMID: 6609199
  36. Biological activities of v-myc and rearranged c-myc oncogenes in rat fibroblast cells in culture.
    Proc Natl Acad Sci U S A. 1984 Sep;81(18):5758-62 PMID: 6091107
  37. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
    Mol Cell Biol. 1984 Sep;4(9):1689-94 PMID: 6092932
  38. Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferon.
    Cell Immunol. 1985 May;92(2):218-25 PMID: 2986852
  39. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF.
    Nature. 1987 Dec 10-16;330(6148):581-3 PMID: 2960901
  40. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells.
    Nature. 1989 Jul 6;340(6228):66-8 PMID: 2662015
  41. Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. Role of phospholipase activation.
    J Biol Chem. 1989 Oct 25;264(30):18128-36 PMID: 2808369
  42. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.
    Nucleic Acids Res. 1990 Jun 25;18(12):3587-96 PMID: 2194165
  43. Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts.
    J Biol Chem. 1993 Sep 5;268(25):18994-9 PMID: 7689564
  44. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.
    Oncogene. 1993 Sep;8(9):2457-67 PMID: 8103211
  45. Direct role for Myc in transcription initiation mediated by interactions with TFII-I.
    Nature. 1993 Sep 23;365(6444):359-61 PMID: 8377829
  46. Production of high-titer helper-free retroviruses by transient transfection.
    Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8392-6 PMID: 7690960
  47. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.
    Cell. 1993 Sep 24;74(6):957-67 PMID: 8402885
  48. Overexpression of major heat shock protein hsp70 inhibits tumor necrosis factor-induced activation of phospholipase A2.
    J Immunol. 1993 Oct 15;151(8):4286-94 PMID: 8409402
  49. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max.
    EMBO J. 1993 Dec 15;12(13):5083-7 PMID: 8262051
  50. The stress-activated protein kinase subfamily of c-Jun kinases.
    Nature. 1994 May 12;369(6476):156-60 PMID: 8177321
  51. Repression of cyclin D1: a novel function of MYC.
    Mol Cell Biol. 1994 Jun;14(6):4032-43 PMID: 8196642
  52. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.
    EMBO J. 1994 Jul 15;13(14):3286-95 PMID: 8045259
  53. Participation of p53 protein in the cellular response to DNA damage.
    Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11 PMID: 1933891
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1997-12-15
Pages
7382-92
Language
English
Region
England
NLM ID
8208664
PMCID
PMC1170338
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]